Holen Sie sich die Stockscreener-App
4.05
0.74%
0.02
Schlusskurs vom Vortag:
$4.03
Offen:
$4.04
24-Stunden-Volumen:
851.55K
Relative Volume:
0.19
Marktkapitalisierung:
$494.72M
Einnahmen:
$43.40M
Nettoeinkommen (Verlust:
$-68.98M
KGV:
-7.8458
EPS:
-0.5162
Netto-Cashflow:
$-50.94M
1W Leistung:
-3.79%
1M Leistung:
+11.23%
6M Leistung:
-19.60%
1J Leistung:
+49.26%
1-Tages-Spanne:
$4.00
$4.11
1-Wochen-Bereich:
$4.00
$4.41
52-Wochen-Spanne:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Firmenname
Aquestive Therapeutics Inc
Sektor
Telefon
908-941-1900
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.055 | 491.67M | 43.40M | -68.98M | -50.94M | -0.5162 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.82 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
114.91 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.05 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.75 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
541.45 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-28 | Eingeleitet | Raymond James | Outperform |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-04-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-03 | Eingeleitet | Lake Street | Buy |
| 2018-08-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-08-20 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha
Class Action Lawsuit Filed Against Aquestive Therapeutics - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - PR Newswire
Aquestive Therapeutics Investors Eligible for Securities Fraud Lawsuit - National Today
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Financial Times
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - Bluefield Daily Telegraph
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aquestive therapeutics chief legal officer Braender sells $167k in stock - Investing.com Canada
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - The Killeen Daily Herald
Aquestive Therapeutics SVP Cioffi sells $105k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock By Investing.com - Investing.com Canada
Aquestive Therapeutics SVP Cioffi sells $105k in shares - Investing.com
Aquestive Therapeutics CEO Barber sells $753,965 in stock - Investing.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) COO Sells 45,791 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Peter Boyd Sells 29,814 Shares - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) SVP Melina Cioffi Sells 25,311 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CFO Sells 58,254 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Lori Braender Sells 40,102 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CEO Sells 180,677 Shares of Stock - MarketBeat
AQST Investors Encouraged to Seek Lead Plaintiff Role in Aquestive Therapeutics Securities Class Action Case with Johnson Fistel - lincolnjournal.com
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
HC Wainwright Issues Optimistic Forecast for AQST Earnings - MarketBeat
Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval - Seeking Alpha
Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data - MarketBeat
AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST - GlobeNewswire Inc.
Rosen Law Firm Urges Aquestive Therapeutics, Inc. (NASDAQ: AQST) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
What’s the RSI of Aquestive Therapeutics Inc. stockWeekly Trading Summary & Intraday High Probability Setup Alerts - mfd.ru
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky - Business Wire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) S - GuruFocus
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-03-10 | AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
What is HC Wainwright's Estimate for AQST FY2027 Earnings? - MarketBeat
Aquestive Therapeutics Targets Q3 Anaphylm FDA Resubmission After CRL, Details Launch Plans at Leerink Conf - MarketBeat
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Aquestive CMO gets 75,000 RSUs plus 50,000 stock options to join company - Stock Titan
Contact Levi & Korsinsky by May 4, 2026 Deadline to Join Class Action Against Aquestive Therapeutics, Inc.(AQST) - GlobeNewswire
AQST Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
2026-03-09 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch - TipRanks
Market Review: Will Aquestive Therapeutics Inc benefit from government policyGlobal Markets & Stepwise Trade Signal Implementation - baoquankhu1.vn
AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-08) - Seeking Alpha
2026-03-08 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Will Aquestive Therapeutics Inc. stock continue upward momentumPortfolio Profit Report & Expert-Curated Trade Recommendations - Naître et grandir
Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Barber Daniel | President and CEO |
Mar 10 '26 |
Sale |
4.17 |
180,677 |
753,965 |
1,004,753 |
| BRAENDER LORI J | Chief Legal Officer |
Mar 10 '26 |
Sale |
4.17 |
40,102 |
167,346 |
442,879 |
| Cioffi Melina | SVP, Regulatory Affairs |
Mar 10 '26 |
Sale |
4.17 |
25,311 |
105,623 |
274,867 |
| TOTH A ERNEST JR | Chief Financial Officer |
Mar 10 '26 |
Sale |
4.17 |
58,254 |
243,094 |
376,112 |
| Korczynski Sherry | Chief Commercial Officer |
Mar 10 '26 |
Sale |
4.17 |
15,741 |
65,687 |
241,117 |
| Jung Cassie | Chief Operating Officer |
Mar 10 '26 |
Sale |
4.17 |
45,791 |
191,086 |
274,980 |
0.26%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):